ACB $10.310 (-3.73%)

ACNNF $0.116 (-0.09%)

AERO $4.500 (0.67%)

AGEEF $0.085 (-6.18%)

ALEAF $0.443 (-10.33%)

AMMJ $0.115 (6.8%)

APHA $4.660 (-3.12%)

ARNA $64.630 (0.31%)

ATT:CNX $0.080 (0%)

ATTBF $0.007 (-7.1%)

AUSA:CNX $0.180 (5.88%)

AUSAF $0.131 (5.15%)

AVXL $4.240 (-6.81%)

BAMM:CNX $0.325 (1.56%)

BBM:CNX $0.050 (-9.09%)

BBRRF $0.044 (3.52%)

BE:CNX $0.005 (0%)

BIO:CNX $0.080 (-5.88%)

BLEVF $0.004 (22.22%)

BLIS:CNX $0.315 (0%)

BLO:CNX $0.485 (0%)

BLOZF $0.370 (-1.33%)

BUDZ $0.267 (1.14%)

BXNG $0.520 (-10.34%)

CADMF $0.718 (-2.95%)

CALI:CNX $0.080 (-15.79%)

CANN $0.398 (0.82%)

CARA $16.980 (-1.28%)

CBII:CNX $0.115 (-4.17%)

CBIIF $0.080 (-9.81%)

CBWTF $0.175 (-1.41%)

CGC $17.520 (-8.8%)

CGRW $0.082 (-4.53%)

CHOO:CNX $0.100 (-4.76%)

CHOOF $0.075 (-2.44%)

CNBX $0.191 (-5.3%)

CNGGF $0.303 (-8.35%)

CODI $17.020 (2.35%)

CPMD $1.950 (-0.51%)

CRBP $6.330 (-11.47%)

CRON $5.870 (-15.9%)

CROP:CNX $0.015 (0%)

CRTPF $1.700 (-2.16%)

CRXPF $0.030 (-38.02%)

CSI:CNX $0.920 (0%)

CURR $1.600 (-1.23%)

CVSI $0.680 (-13.6%)

DIGP $0.035 (-8.73%)

DXBRF $0.140 (0%)

EAPH $0.001 (0%)

EAT:CNX $0.025 (0%)

EEVVF $0.055 (-0.36%)

EMHTF $0.145 (-2.35%)

EPWCF $0.036 (0.03%)

EVIO $0.019 (-1.03%)

FFRMF $0.031 (-3.13%)

FFT:CNX $0.040 (0%)

FNNZF $0.068 (-14.82%)

GGTTF $0.090 (-8.12%)

GLDFF $0.019 (-1.6%)

GLH:CNX $0.025 (25%)

GNBT $0.450 (-5.26%)

GRIN:CNX $0.125 (4.17%)

GRWG $8.690 (-4.61%)

GSTR:CNX $0.095 (0%)

GTBIF $14.440 (4.34%)

GTII:CNX $19.190 (4.12%)

GWPH $132.100 (-2.1%)

HEXO $0.697 (-0.75%)

HHPHF $0.006 (-54.55%)

HLSPY $0.435 (3.53%)

HMLSF $5.275 (-4.45%)

HMPPF $0.498 (0%)

HRVOF $0.060 (-8.12%)

HSTRF $0.105 (-7.59%)

HUGE:CNX $4.000 (-3.61%)

IAN:CNX $0.305 (0%)

IGC $0.704 (3.5%)

IGXT $0.213 (11.84%)

IIPR $111.170 (3.85%)

IMLFF $5.700 (8.06%)

INQD $0.003 (1.27%)

IONC:CNX $0.015 (0%)

IONKF $0.017 (-10.29%)

ISOL:CNX $0.055 (0%)

ISOLF $0.041 (-8.22%)

ITHUF $0.060 (-11.5%)

IVITF $0.013 (-3.08%)

JWCAF $0.009 (190.32%)

KALTF $0.001 (0%)

KBEV:CNX $0.070 (0%)

KBEVF $0.056 (7.06%)

KHRNF $0.370 (-1.39%)

KSHB $0.695 (2.21%)

LHS:CNX $0.500 (0%)

LHSIF $0.370 (-1.33%)

LOVE:CNX $0.095 (-5%)

LXRP $0.394 (-1.53%)

LXX:CNX $0.520 (-3.7%)

MCIG $0.028 (0%)

MEDIF $0.748 (-5.03%)

MGWFF $0.060 (3.45%)

MICWF $0.052 (-0.02%)

MJ:CNX $0.035 (0%)

MJNA $0.014 (-1.4%)

MNTR $0.094 (11.9%)

MRRCF $0.004 (0%)

MWM:CNX $0.065 (0%)

MYM:CNX $0.070 (0%)

MYMMF $0.053 (2.5%)

NCNNF $0.139 (-3.34%)

NDVAF $0.223 (6.33%)

NGW:CNX $0.280 (-3.45%)

NRXCF $0.100 (-7.33%)

NSPDF $0.052 (-1.39%)

NTEC $0.389 (-5.86%)

NVTQF $0.451 (-4.04%)

NWKRF $0.424 (0%)

NXGWF $0.209 (-2.02%)

NXTTF $0.213 (-8.2%)

OH:CNX $5.330 (0%)

ORHOF $4.050 (0%)

OWCP $0.009 (5.75%)

PHCG $0.450 (0%)

PHVAF $0.042 (-1.65%)

PILL:CNX $0.700 (0%)

PKG:CNX $0.095 (0%)

PLPRF $0.449 (-3.27%)

PLUS:CNX $0.610 (-3.17%)

PMCB $0.014 (-11.95%)

PNPL $0.280 (0%)

POTN $0.016 (-3.66%)

PRCNF $0.010 (0%)

PTNYF $0.071 (-3.13%)

QCA:CNX $0.108 (2.38%)

RDDTF $0.106 (-2.89%)

RLLVF $0.028 (12%)

RMHB $0.032 (-3.03%)

RQB:CNX $0.005 (0%)

RQHTF $0.196 (-3.6%)

RVVQF $0.015 (1.4%)

SLNG:CNX $0.140 (-3.45%)

SMG $156.760 (-0.1%)

SNN:CNX $0.155 (0%)

SNNVF $0.120 (14.29%)

SOL:CNX $0.375 (-2.6%)

SOLCF $0.285 (0.11%)

SPLIF $0.017 (-6.72%)

SPRWF $0.155 (-6.49%)

SRNA $0.042 (59.52%)

STEM:CNX $0.500 (-5.66%)

STMH $0.410 (2.5%)

SUN:CNX $0.160 (3.23%)

TBPMF $0.155 (-3.44%)

TCAN:CNX $1.220 (-5.43%)

TCNAF $0.900 (-7.09%)

TER:CNX $5.000 (9.89%)

TGEN $0.810 (-4.71%)

TGIF:CNX $0.065 (0%)

TGIFF $0.049 (-0.81%)

THC:CNX $0.175 (-10.26%)

THCBF $0.132 (-7.71%)

TLRY $7.760 (-4.32%)

TOKI:CNX $0.030 (0%)

TRLFF $0.026 (-10.34%)

TRSSF $3.720 (7%)

TRTC $0.083 (-4.43%)

TURV $0.108 (0.09%)

VBIO $0.180 (5.88%)

VIDA:CNX $0.055 (10%)

VIN:CNX $0.025 (0%)

VPRB $0.008 (11.11%)

VRNDF $0.450 (-0.46%)

VRT:CNX $0.145 (0%)

VRTHF $0.119 (-0.42%)

VVCIF $0.185 (2.15%)

WAYL:CNX $0.740 (0%)

WDDMF $0.272 (0.89%)

WLDFF $0.120 (0%)

XXII $0.741 (-0.56%)

ZDPY $0.140 (0%)

ZYNE $4.300 (3.61%)

Loading...
GW Pharmaceuticals’ (GWPH) Epidiolex product was granted the Orphan Drug Designation from the European Medicines Agency (EMA) for the treatment of Lennox-Gastaut Syndrome. The EMA previously grated this designation for Epidiolex for Dravet syndrome. CEO Justin Gover said the company plans to submit a New Drug Application with FDA in the middle of 2017 and […]
To access this content, you must purchase Technical420 Premium Membership, Yearly or Technical420 Premium Membership, Monthly.